We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Goserelin plus endocrine treatments maintained long-term clinical benefit in a male patient with advanced breast cancer.
- Authors
Hang Jiang; Tao Wang; Zefei Jiang
- Abstract
Background Goserelin plus aromatase inhibitors (AI) have already been used in male advanced breast cancer, but the cases that fulvestrantin male breast cancer are rare. Case presentation Here we report a case of long-term (3 years) response to Goserelin plus continuing endocrine treatments given for a male advanced breast cancer. The patient prolongs his life with high life quality, and has more time with his family. Conclusion Goserelin plus endocrine treatments may benefit male breast cancer.
- Subjects
GOSERELIN; BREAST cancer treatment; CANCER in men; ENDOCRINE glands; IMMUNOHISTOCHEMISTRY
- Publication
World Journal of Surgical Oncology, 2014, Vol 12, Issue 1, p311
- ISSN
1477-7819
- Publication type
Case Study
- DOI
10.1186/1477-7819-12-393